Defragmenting Data for the Future of Pharma R&D
Innovation in pharma today means faster ‘time to insight’. However, trying to innovate with disconnected, fragmented data is slow, costly and frustrating—for both pharma companies and patients. Today’s data resides
within disparate sources scattered across the organization and beyond. This
data can only provide value when it’s integrated—meaningfully and securely
linked, accessible, and resilient to new sources and unintended use cases.
Read more...